Alternatives to Levemir If You Can't Fill Your Prescription

Updated:

March 13, 2026

Author:

Peter Daggett

Summarize this blog with AI:

Can't find Levemir? Here are the best alternative long-acting insulins for 2026, including how they compare in dosing, cost, and availability.

What to Do When You Can't Find Levemir

If you've been prescribed Levemir (Insulin Detemir) and your pharmacy keeps telling you it's out of stock, you're not alone. With Novo Nordisk discontinuing Levemir, millions of patients are facing the same problem in 2026.

The good news: there are several effective alternative long-acting insulins that your doctor can switch you to. In this guide, we'll explain what Levemir is, how it works, and walk you through the best alternatives available right now — so you can have an informed conversation with your doctor.

For more on why Levemir is so scarce, read our article on why Levemir is so hard to find in 2026.

What Is Levemir and How Does It Work?

Levemir is a long-acting insulin analogue made by Novo Nordisk. Its active ingredient is Insulin Detemir, a modified form of human insulin that has a fatty acid chain attached to it. This fatty acid chain causes the insulin to bind to a protein called albumin in your blood after injection, which slows down how quickly your body absorbs it.

The result is a steady, gradual release of insulin that can last up to 24 hours. This makes Levemir effective as a "basal" insulin — the background insulin that keeps your blood sugar stable between meals and while you sleep.

Levemir is approved for:

  • Type 1 diabetes in adults and children aged 2 and older (used alongside a rapid-acting mealtime insulin)
  • Type 2 diabetes in adults (used alone or with other diabetes medications)

For a complete breakdown, see our post on what Levemir is and how to use it.

Why You Might Need an Alternative

There are two main reasons patients are looking for Levemir alternatives in 2026:

  1. Discontinuation: Novo Nordisk is phasing out Levemir production. Supply has been declining since late 2024 and continues to shrink.
  2. No biosimilar: Unlike Insulin Glargine (Lantus), there is no biosimilar version of Insulin Detemir, so no other manufacturer can step in to produce it.

If you can still find Levemir, Medfinder can help you locate it. But if it's no longer available in your area, switching to an alternative is the responsible next step.

Alternative 1: Insulin Glargine (Lantus, Basaglar, Semglee)

Insulin Glargine is the most commonly prescribed long-acting insulin in the world and the most likely alternative your doctor will suggest. It works similarly to Levemir — providing a steady release of insulin over approximately 24 hours — but uses a different mechanism (it forms micro-crystals under the skin that dissolve slowly).

Key facts:

  • Brand names: Lantus (original), Basaglar (biosimilar), Semglee (interchangeable biosimilar)
  • Dosing: Once daily, usually at the same time each day
  • Duration: Up to 24 hours
  • Availability: Widely available in 2026, especially the biosimilar versions
  • Cost: Lantus: ~$300-$400 per box of pens. Biosimilars (Basaglar, Semglee): ~$150-$300 per box

Insulin Glargine biosimilars are often cheaper and more widely available than Levemir, making this a practical switch for many patients.

Alternative 2: Insulin Degludec (Tresiba)

Insulin Degludec, sold under the brand name Tresiba, is an ultra-long-acting insulin also made by Novo Nordisk. It has the longest duration of action of any basal insulin — over 42 hours — which means it offers more flexibility in dosing time. If you're someone who sometimes forgets your injection or can't always take it at the exact same time, Tresiba may be a good fit.

Key facts:

  • Brand name: Tresiba
  • Dosing: Once daily, with flexible timing (can vary by up to 8 hours from day to day)
  • Duration: Over 42 hours
  • Availability: Generally available in 2026
  • Cost: ~$400-$550 per box of pens without insurance

Tresiba tends to be more expensive than Insulin Glargine biosimilars, but its ultra-long duration and dosing flexibility are advantages for some patients.

Alternative 3: NPH Insulin (Humulin N, Novolin N)

NPH Insulin (also called isophane insulin) is an intermediate-acting insulin that has been available for decades. It's not a perfect one-to-one replacement for Levemir because it doesn't last as long and has a more noticeable "peak" in activity (which can increase the risk of low blood sugar at certain times of day). However, it is widely available and much cheaper.

Key facts:

  • Brand names: Humulin N (Eli Lilly), Novolin N (Novo Nordisk)
  • Dosing: Usually twice daily
  • Duration: 12-18 hours
  • Availability: Very widely available; can be purchased over the counter in some states
  • Cost: ~$50-$150 per vial, making it one of the most affordable insulin options

NPH Insulin may be a good temporary option if cost is a major concern or if other long-acting insulins are also unavailable. Your doctor will need to adjust your dose and schedule carefully.

Alternative 4: Insulin Glargine-yfgn (Semglee)

Semglee deserves special mention because it is the first interchangeable biosimilar insulin in the U.S. This means it can be substituted for Lantus at the pharmacy without needing a new prescription from your doctor (similar to how generic drugs work). It's typically cheaper than brand-name Lantus.

Key facts:

  • Dosing: Same as Lantus — once daily
  • Cost: ~$150-$250 per box of pens
  • Availability: Widely available in 2026

How to Switch Safely

Switching from one insulin to another is not something you should do on your own. Even though these alternatives work similarly to Levemir, the doses are not always interchangeable. Here's what to expect:

  • Your doctor will calculate a new starting dose based on your current Levemir dose
  • You may need to check your blood sugar more frequently during the first 1-2 weeks
  • Your dose may need to be adjusted up or down based on your readings
  • Some patients experience slightly different side effect profiles with different insulins

For more information about side effects to watch for, see our post on Levemir side effects.

Final Thoughts

Losing access to the insulin you've relied on is stressful, but you have good alternatives. Insulin Glargine (especially the biosimilar versions like Basaglar and Semglee) is the most common and affordable switch. Insulin Degludec (Tresiba) offers ultra-long action and flexible dosing. And NPH Insulin is a budget-friendly option that's available almost everywhere.

Start by talking to your doctor about which alternative makes the most sense for your situation. And if you want to try to find Levemir first, use Medfinder to check real-time availability at pharmacies near you.

What is the closest alternative to Levemir?

Insulin Glargine (sold as Lantus, Basaglar, or Semglee) is the closest alternative to Levemir. Both are long-acting basal insulins given once daily. Insulin Glargine is widely available and has biosimilar options that are often cheaper.

Can I switch from Levemir to Lantus without changing my dose?

Not necessarily. While Levemir and Lantus are both long-acting insulins, the doses are not always equivalent. Your doctor will calculate an appropriate starting dose for the new insulin and may adjust it based on your blood sugar readings over the first few weeks.

Is there a cheaper alternative to Levemir?

Yes. NPH Insulin (Humulin N or Novolin N) costs approximately $50-$150 per vial, compared to $350-$500 for Levemir. Biosimilar Insulin Glargine products like Semglee ($150-$250 per box) are also cheaper. Talk to your doctor about which option is right for you.

Will my insurance cover a Levemir alternative?

Most insurance plans cover at least one long-acting insulin. Insulin Glargine (especially biosimilars like Basaglar and Semglee) is on most formularies. Check with your insurance company or ask your pharmacist to run a test claim to see what your copay would be.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy